Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs: original research - Lepper, Alisa; Bitsch, Rebekka; Özbay Kurt, Feyza Gül; Arkhypov, Ihor; Lasser, Samantha; Utikal, Jochen; Umansky, Viktor (OncoImmunology, 2023)
Gesehen am 16.04.2024